METABOLIC / SINGLE
CAGRILINTIDE
5MG · 10MGThis content is intended for educational and research reference only and does not constitute medical advice, diagnosis, or treatment. Experimental compounds are for research use only and are not for human consumption. Always consult qualified healthcare providers before starting any therapy.
Research Overview
A long-acting amylin-receptor agonist studied in appetite-regulation and weight-management research.
Available Strengths
- 5MG (CGL5)
- 10MG (CGL10)
Research Protocol
Reference titration schedule
| Period | Dose | U-100 units | Volume |
|---|---|---|---|
| Weeks 1–2 | 0.6 mg | 36 | 0.36 mL |
| Weeks 3–4 | 1.2 mg | 72 | 0.72 mL |
| Weeks 5–6 | 2.4 mg | 144 | 1.44 mL |
| Weeks 7–16+ | 4.5 mg | 270 | 2.7 mL |
Reconstitution
≈1.67 mg/mL once reconstituted
- Draw 3.0 mL of bacteriostatic water per 5 mg vial.
- Inject slowly along the vial wall; swirl gently until dissolved.
Research context
Activates central amylin receptors, studied for promoting satiety and slowing gastric emptying; a half-life of roughly 160–195 hours supports once-weekly dosing in the reference protocol.
Storage
−20°C, dry and dark. 2–8°C, use within 30 days, avoid freeze-thaw cycles.
Research Notes
- For educational and research reference only. Not medical advice and not intended for unsupervised human use.
References
Source reference: PeptideDosages.com · 2026-08-18 · Exact strength match with the cited source